429

Compound name
Apatinib
Alt Name
rivoceranib
Compound Image
Apatinib_Rivoceranib.png
SMILES
C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4
MW
397.50
Brutto
C24H23N5O
InChI
InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)
InChI Key
WPEWQEMJFLWMLV-UHFFFAOYSA-N
Approval Jurisdiction
2014 China 2018FDA
Approved for clinical use
Gastric Cancer, NSCLC
CAS
811803-05-1
PubChem CID
11315474
Action
VEGFR2; KIT; Src
Approved Drug List
1
Commercial Vendor
Elevar